Author Correction: BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction (Cancer Gene Therapy, (2019), 10.1038/s41417-018-0068-4)

Zhicheng Yao, Shida Yang, Hongyou Zhao, Huike Yang, Xin Jiang*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

All animal experiments were approved by the Animal Care and Use Committee (ACUC), Louisiana State University Health Science Center and not The People’s Hospital of Liaoning Province as indicated in the original version of the Article. The PDF and HTML versions of the Article have been modified accordingly.

Original languageEnglish
Pages (from-to)257
Number of pages1
JournalCancer Gene Therapy
Volume26
Issue number7-8
DOIs
Publication statusPublished - 1 Jul 2019
Externally publishedYes

Fingerprint

Dive into the research topics of 'Author Correction: BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction (Cancer Gene Therapy, (2019), 10.1038/s41417-018-0068-4)'. Together they form a unique fingerprint.

Cite this